Integrated Annual Report

Overview

The report presents PT Organon Pharma Indonesia Tbk's 2023 annual and sustainability performance in one integrated publication. It reports revenue of Rp2,747,529,515 thousand and 257 employees, alongside electricity, water and waste data. The company states a net-zero emissions target for 2025 and describes an ESG governance structure involving the Board of Directors, ESG Committee, Talent Committee and Audit Committee. It also discloses that no external assurance was used for the sustainability report.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Language: English, Indonesian
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services